Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TRIP, M. D")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

Hyperréactivité plaquettaire et pathologie cardiovasculaire = Platelet hyperreactivity and cardiovascular diseaseTRIP, M. D; DROUET, L.STV. Sang thrombose vaisseaux. 1994, Vol 6, Num 3, pp 189-194, issn 0999-7385Article

Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidismTRIP, M. D; WIERSINGA, W; PLOMP, T. A et al.The American journal of medicine. 1991, Vol 91, Num 5, pp 507-511, issn 0002-9343Article

A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemiaWITTEKOEK, M. E; MOLL, E; PIMSTONE, S. N et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 11, pp 2708-2713, issn 1079-5642Article

The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patientsJANSEN, A. C. M; VAN AALST-COHEN, E. S; TANCK, M. W et al.Journal of internal medicine. 2004, Vol 256, Num 6, pp 482-490, issn 0954-6820, 9 p.Article

Immunoradiometric assay of thyrotropin in plasma: its value in predicting response to thyroliberin stimulation and assessing thyroid function in amiodarone-treated patientsWIERSINGA, W. M; ENDERT, E; TRIP, M. D et al.Clinical chemistry (Baltimore, Md.). 1986, Vol 32, Num 3, pp 433-436, issn 0009-9147Article

Two cases of aminodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while aminodarone was continuedTRIP, M. D; DÜREN, D. R; WIERSINGA, W. M et al.British heart journal. 1994, Vol 72, Num 3, pp 266-268, issn 0007-0769Article

A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemiaAVIS, H. J; VISSERS, M. N; STEIN, E. A et al.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 8, pp 1803-1810, issn 1079-5642, 8 p.Article

Long term survivors of childhood brain cancer have an increased risk for cardiovascular diseaseHEIKENS, J; UBBINK, M. C; VAN DER PAL, H. P. J et al.Cancer. 2000, Vol 88, Num 9, pp 2116-2121, issn 0008-543XArticle

Molecular basis of genetic dyslipidemiaMOLHUIZEN, H. O. F; DEFESCHE, J. C; TRIP, M. D et al.Cardiovascular reviews & reports. 1999, Vol 20, Num 11, pp 607-619, issn 0197-3118Article

The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosisVERHOEFF, B. J; TRIP, M. D; PRINS, M. H et al.Atherosclerosis. 1998, Vol 141, Num 1, pp 161-166, issn 0021-9150Conference Paper

Platelet hyperreactivity and prognosis in survivors of myocardial infarctionTRIP, M. D; MANGER CATS, V; VAN CAPELLE, F. J. L et al.The New England journal of medicine. 1990, Vol 322, Num 22, pp 1549-1554, issn 0028-4793Article

Colesevelam Added to Combination Therapy With a Statin and Ezetimibe in Patients With Familial Hypercholesterolemia: A 12-Week, Multicenter, Randomized, Double-Blind, Controlled TrialHUIJGEN, Roeland; ABBINK, Evertine J; KASTELEIN, John J. P et al.Clinical therapeutics. 2010, Vol 32, Num 4, pp 615-625, issn 0149-2918, 11 p.Article

Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemiaVAN WISSEN, S; SMILDE, T. J; TRIP, M. D et al.Heart (London 1996). 2003, Vol 89, Num 8, pp 893-896, issn 1355-6037, 4 p.Article

Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular diseaseWITTEKOEK, M. E; DE GROOT, E; PRINS, M. H et al.Atherosclerosis. 1999, Vol 146, Num 2, pp 271-279, issn 0021-9150Article

Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular diseaseFRANCO, R. F; ZAGO, M. A; TRIP, M. D et al.British journal of haematology. 1998, Vol 102, Num 5, pp 1172-1175, issn 0007-1048Article

Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidismWIERSINGA, W. M; TOUBER, J. L; TRIP, M. D et al.The Journal of clinical endocrinology and metabolism. 1986, Vol 63, Num 2, pp 485-491, issn 0021-972XArticle

Löffler's endomyocarditis in the idiopathic hypereosinophilic syndromeCORSSMIT, E. P. M; TRIP, M. D; DURRER, J. D et al.Cardiology. 1999, Vol 91, Num 4, pp 272-276, issn 0008-6312Article

Long-term LDL-c lowering in heterozygous familial hypercholesterolemia normalizes carotid intima-media thicknessSIVAPALARATNAM, S; VAN LOENDERSLOOT, L. L; HUTTEN, B. A et al.Atherosclerosis. 2010, Vol 212, Num 2, pp 571-574, issn 0021-9150, 4 p.Article

Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemiaNETEA, M. G; HIJMANS, A; VAN WISSEN, S et al.European journal of clinical investigation. 2004, Vol 34, Num 2, pp 94-99, issn 0014-2972, 6 p.Article

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP) : a prospective, randomised, double-blind trialSMILDE, T. J; VAN WISSEN, S; WOLLERSHEIM, H et al.Lancet (British edition). 2001, Vol 357, Num 9256, pp 577-581, issn 0140-6736Article

Abnormalities in liver function and coagulation profile following the Fontan procedureVAN NIEUWENHUIZEN, R. C; PETERS, M; LUBBERS, L. J et al.Heart (London 1996). 1999, Vol 82, Num 1, pp 40-46, issn 1355-6037Article

The 20210 G→ A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic diseaseFRANCO, R. F; TRIP, M. D; TEN CATE, H et al.British journal of haematology. 1999, Vol 104, Num 1, pp 50-54, issn 0007-1048Article

Failure to detect Fabry patients in a cohort of prematurely atherosclerotic malesVEDDER, A. C; GERDES, V. E. A; POORTHUIS, B. J. H. M et al.Journal of inherited metabolic disease. 2007, Vol 30, Num 6, pp 988-988, issn 0141-8955, 1 p.Article

Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemiaVAN DAM, M; ZWART, M; DE BEER, F et al.Heart (London 1996). 2002, Vol 88, Num 3, pp 234-238, issn 1355-6037Article

Molecular genetic testing for familial hypercholesterolemia : spectrum of LDL receptor gene mutations in the NetherlandsLOMBARDI, M. P; REDEKER, E. J. W; DEFESCHE, J. C et al.Clinical genetics. 2000, Vol 57, Num 2, pp 116-124, issn 0009-9163Article

  • Page / 2